CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $68.7 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.19 per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.62 per share.

The biopharmaceutical company posted revenue of $40.4 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $12.1 million.

Agios Pharmaceuticals shares have increased 52 percent since the beginning of the year. The stock has risen 48 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO